Third, while our EdU, Transwell, CCK-8, and xenograft assays confirmed that POLR2J4 promotes glioma proliferation, migration, and chemoresistance, the molecular mechanisms—such as its regulation of PI3K–Akt signaling or immune checkpoints—remain to be elucidated. The gene discussed is POLR2J4; the disease is central nervous system cancer.